Kestra Medical Technologies, Ltd. KMTS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 30.97M | 28.64M | 24.55M | 22.57M | 19.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.97M | 28.64M | 24.55M | 22.57M | 19.37M |
| Cost of Revenue | 13.47M | 12.96M | 11.65M | 11.14M | 10.52M |
| Gross Profit | 17.50M | 15.68M | 12.91M | 11.42M | 8.85M |
| SG&A Expenses | 48.36M | 49.39M | 42.70M | 38.30M | 33.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.63M | 67.98M | 59.32M | 54.32M | 48.25M |
| Operating Income | -37.66M | -39.34M | -34.77M | -31.76M | -28.88M |
| Income Before Tax | -44.04M | -38.64M | -34.13M | -32.75M | -25.79M |
| Income Tax Expenses | 50.00K | 192.00K | 35.00K | 34.00K | 33.00K |
| Earnings from Continuing Operations | -44.09M | -38.84M | -34.17M | -32.79M | -25.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.09M | -38.84M | -34.17M | -32.79M | -25.83M |
| EBIT | -37.66M | -39.34M | -34.77M | -31.76M | -28.88M |
| EBITDA | -34.99M | -37.02M | -32.78M | -29.38M | -26.85M |
| EPS Basic | -0.75 | -0.67 | -0.61 | -0.64 | -0.50 |
| Normalized Basic EPS | -0.40 | -0.41 | -0.38 | -0.40 | -0.31 |
| EPS Diluted | -0.75 | -0.67 | -0.61 | -0.64 | -0.50 |
| Normalized Diluted EPS | -0.40 | -0.41 | -0.38 | -0.40 | -0.31 |
| Average Basic Shares Outstanding | 58.57M | 58.40M | 55.85M | 51.38M | 51.30M |
| Average Diluted Shares Outstanding | 58.57M | 58.40M | 55.85M | 51.38M | 51.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |